The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Amneal Pharmaceuticals's share price is $7.39.
Amneal Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $8.97. Hence, Amneal Pharmaceuticals's PS Ratio for today is 0.82.
The historical rank and industry rank for Amneal Pharmaceuticals's PS Ratio or its related term are showing as below:
AMRX'
s PS Ratio Range Over the Past 10 Years
Min: 0.09 Med: 0.37 Max: 2.31
Current: 0.82
During the past 9 years, Amneal Pharmaceuticals's highest PS Ratio was 2.31. The lowest was 0.09. And the median was 0.37.
AMRX's PS Ratio is ranked better than 76.58% of 965
companies
in the Drug Manufacturers industry
Industry Median: 2.07
vs AMRX: 0.82
Amneal Pharmaceuticals Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Amneal Pharmaceuticals was -33.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -13.10% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -4.00% per year.
During the past 9 years, Amneal Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 14.10% per year. The lowest was -13.10% per year. And the median was 3.90% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Amneal Pharmaceuticals's PS Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Amneal Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amneal Pharmaceuticals's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amneal Pharmaceuticals's PS Ratio distribution charts can be found below:
* The bar in red indicates where Amneal Pharmaceuticals's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Amneal Pharmaceuticals's Share Price of today is $7.39. Amneal Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.97.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Amneal Pharmaceuticals (NAS:AMRX) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Amneal Pharmaceuticals PS Ratio Related Terms
Thank you for viewing the detailed overview of Amneal Pharmaceuticals's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMRX has been successfully added to your 